 |
International press release center - we
bring you the latest company news |
Latest report from visiongain: Top 10 Biotech Companies 2004: Innovators and Leaders in the Market |
|
NewsreleaseDate:
2004-11-16
San Francisco, CA and London, UK; 16 November 2004 – visiongain.
More than 325 million people worldwide have been helped by the more than 130 biotechnology drugs and vaccines approved by the US FDA. Of the biotech medicines on the market, 70 per cent were approved in the last six years.
Market capitalization of the biotech industry was $224 billion in 2002 and the industry has more than tripled in size since 1992, with revenues increasing from $8 billion in 1992 to $27.6 billion in 2001. Biotechnology is one of the most research-intensive industries in the world. The U.S. biotech industry spent $15.6 billion on research and development in 2001. Thus the life sciences hold considerable promise as an investment sector. In recent years biotech has established itself as a successful industry in its own right, with a number of high profile approvals by leading companies contributing to the profile of the industry.
From the standpoint of growth of Earnings Per Share (EPS), the leading five biotech’s outperformed the leading five pharmaceutical companies. When we take into account the fact that the future of the global pharmaceutical industry is suffering from a developmental 'dry spell' where their product pipelines are concerned, the role of biotech is becoming increasingly prominent in their future.
“When we take into account the fact that the future of the global pharmaceutical industry is suffering from a developmental 'dry spell' where their product pipelines are concerned, the role of biotech is becoming increasingly prominent in their future”, says John Waslif, Pharmaceutical report Analyst. The importance of innovative biotech’s in the future of healthcare is reflected in the dollar value of the alliances between Pharma and biotech - in the early 1990s, the average alliance was valued in the region of $40 million, in 2003 it was nearer $100 million.
In recent years biotech has established itself as a successful industry in its own right, with a number of high profile approvals by leading companies contributing to the profile of the industry. There were 35 biotechnology drug approvals in 2002 - more than in any other year in the history of the industry. Of the 35 biotech approvals, 23 were for new products and those remaining were for new indications granted to already-marketed drugs. Of these biotech-derived products, five are well on their way to attaining blockbuster sales status.
“It is into this burgeoning market that antisense developers hope to make an impact. Although antisense drugs are traditionally grouped into the biotech sector, the ways by which these drugs have been developed to work are singular in nature and their success would by no doubt be revolutionary” adds Waslif.
# # #
If you are interested in an overview of Top 10 Biotech Companies 2004: Innovators and Leaders in the Market - Please send an email to Ms. Senh Ip Senh.ip@visiongain.com including: full name, Title of publication, contact telephone number, Email, and details of where you saw this release. Upon receipt of this information, an overview will be emailed to you.
Background:
Visiongain is one of the fastest growing and most innovative independent media companies in Europe today. Based in London, UK, visiongain produce a host of business-2-business conferences, newsletters, management reports and E-Zines focusing on the Financial markets, the Pharmaceutical, Telecoms industries and currently the Defence sector.
Visiongain publish reports produced by their in-house analysts of qualified experts in their field. Visiongain have firmly established themselves as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.
Visiongain also have an event division, b2b Conferences, works in tandem with their analytical reports to provide a forum for key issues within the Telecoms and Pharmaceutical professionals.
For more Pharmaceutical information, please contact our website on:
Http://www.epharmaceuticalnews.com
For information on visiongain, please visit the website: Http://www.visiongain.com
For additional information contact:
Ms.Senh Ip
visiongain
40 Tooting High St,
London SW17 ORG, UK
Tel: +44 (0) 20 8767 6711
Fax: +44 (0) 20 8767 5001
Email: Senh.ip@visiongain.com
Http//www.visiongain.com
|
|
[ Add your press release now ]
|
